Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

The damage can lead to both sudden “flares” of inflammation and a slow worsening of symptoms over time. Historically, MS has been broken down into specific subtypes, as detailed below. But the reality ...

In a new book, Ashley Schneider details her journey of running 125 consecutive marathons across America to raise awareness ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

One of the most common viruses in the world could be the cause of lupus, an autoimmune disease with wide-ranging symptoms, ...

Dr. Maximilian Konig, a rheumatologist at Johns Hopkins University, sits for a portrait in the lab where he's studying some ...

Clay Walker has been battling multiple sclerosis (MS) since 1996, and he’s had ups and downs with the disease over the years.

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase ...

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient ...